您的位置:首页 > 产品中心 > 1092697-61-4, 18:0 PEG2000 PE CF
18:0 PEG2000 PE CF
产品编号: | 4095406 |
规格: | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N′-carboxyfluorescein] (ammonium salt), powder |
CAS NO: | 1092697-61-4 |
包装规格: | 500 μG,1 MG |
产品类别: | 进口试剂 |
品牌: | Avanti |
优惠价: | 立即咨询 |
产品价格查看更多规格...
产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
4095406 | 500 μG | 4280 | |||
4095406 | 1 MG | 5750 |
产品别名
1092697-61-4
18:0 PEG2000 PE CF
基本信息
NACRES | NA.25 |
General description【一般描述】 | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N′-carboxyfluorescein] (18:0 PEG2000 PE CF) lipid comprises hydrophilic polyethylene glycol (PEG) polymer in its head groups. DSPE-PEG(2000) micelles exist as spheroid in aqueous solution. |
Application【应用】 | 18:0 PEG2000 PE CF may be used:
|
Biochem/physiol Actions【生化/生理作用】 | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N′-carboxyfluorescein] (18:0 PEG2000 PE CF) micelles aid in nanoparticles based drug delivery. It has potential to solubilize hydrophobic drugs and aid in the controlled release of drugs. 18:0 PEG2000 PE CF also called the DSPE−PEG2000, prevents the uptake of drugs by mononuclear phagocyte system and is a potential drug carrier for cancer therapy. |
产品性质
Assay【测定】 | >99% (TLC) |
form【形式】 | powder |
manufacturer/tradename | Avanti Polar Lipids 810120P |
shipped in【运输】 | dry ice |
storage temp.【储存温度】 | −20℃ |
packaging【包装】 | 5 mL Clear Glass Sealed Ampule (810120P-1mg) 5 mL Clear Glass Sealed Ampule (810120P-500ug) |
安全信息
Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |